MUHC research news
Enlarged prostate: decade-long study demonstrates immediate and long-term benefits of holmium laser treatment
New research presented at the Annual Meeting of the American Urology Association (AUA) in Washington, DC demonstrates that holmium laser therapy is a safe and durable treatment option for Benign Prostatic Hyperplasia (BPH) – an enlargement of the prostate that affects most men as they age.
Results from a new study suggest that one of the most prescribed medications for alcohol dependence may be more effective in some people.
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
As part of McGill's "RaDiCAL" project (Rare Disease Consortium for Autosomal Loci), collaborators in Qatar conducted field research with three patients from biologically interrelated Bedouin families, and sent samples to Canada for analysis by GA JOE – a high-tech genome analyzing machine.
A breakthrough study focusing on the benefits of soy in the prevention of chronic pain after breast cancer surgery has been launched by researchers at the Alan Edwards Pain Management Unit of the McGill University Health Centre (MUHC) and McGill University.
“It’s a global health disaster waiting to happen, even here in Canada, but this new paradigm in TB research may offer an immediate opportunity to improve vaccination and treatment initiatives,” explains Dr. Maziar Divangahi
The Canadian Institutes of Health Research have awarded a $300,000 grant for research focusing on the nature of the immune response induced by the action mechanisms of plant-made Virus-Like Particles to Dr. Louis Vezina, Chief Scientific Officer of Medicago and to Dr. Brian Ward and Dr. Ciriaco Piccirillo of the Research Institute of the McGill University Health Centre and McGill University.
Another step on the road to a cure for diabetes may give hope to the world’s 171 million diabetes sufferers, thanks to collaboration between teams from McGill University and the University of California at San Francisco (UCSF).
People with Parkinson’s disease suffer social difficulties simply because of the way they talk, a McGill University researcher has discovered. Marc Pell, at McGill’s School of Communication Sciences and Disorders, has learned that many people develop negative impressions about individuals with Parkinson’s disease, based solely on how they communicate.
A new study has found that Vitamin D, readily available in supplements or cod liver oil, can counter the effects of Crohn’s disease. John White, an endocrinologist at the Research Institute of the McGill University Health Centre, led a team of scientists who present their findings about the inflammatory bowel disease in the latest Journal of Biological Chemistry.